logo

This website uses cookies to ensure you get the best experience on our website.

Read through our Privacy Policy to learn more.

 Go Back

Mirati: Q1 Earnings Snapshot

By AP News - May 09, 2023, 04:30 PM ET
Last Updated - Apr 05, 2024, 03:02 PM EDT
MRTX_Logo
The biopharmaceutical company posted revenue of $7.2 million in the period, which also beat Street forecasts. Seven analysts surveyed by Zacks expected $5.1 million

Mirati Therapeutics Inc. (MRTX) on Tuesday reported a loss of $184.6 million in its first quarter

SAN DIEGO (AP) — SAN DIEGO (AP) — Mirati Therapeutics Inc. (MRTX) on Tuesday reported a loss of $184.6 million in its first quarter. 

On a per-share basis, the San Diego-based company said it had a loss of $3.18. 

Sponsored

The results surpassed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $3.47 per share. 

The biopharmaceutical company posted revenue of $7.2 million in the period, which also beat Street forecasts. Seven analysts surveyed by Zacks expected $5.1 million. 

_____ 

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a MRTX">Zacks stock report on MRTX at https://www.zacks.com/ap/MRTX

Sponsored
Sponsored
Sponsored
Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
    Phone: +1 (425) 414-0184
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
    Phone: +91 80 4902 2100
4.2 20250415